419 related articles for article (PubMed ID: 28623080)
1. Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.
Lopez JR; Kolster J; Zhang R; Adams J
J Mol Cell Cardiol; 2017 Jul; 108():149-157. PubMed ID: 28623080
[TBL] [Abstract][Full Text] [Related]
2. Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.
Altamirano F; Perez CF; Liu M; Widrick J; Barton ER; Allen PD; Adams JA; Lopez JR
PLoS One; 2014; 9(9):e106590. PubMed ID: 25181488
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.
Lopez JR; Uryash A; Kolster J; Estève E; Zhang R; Adams JA
Mol Neurobiol; 2018 Nov; 55(11):8680-8694. PubMed ID: 29582400
[TBL] [Abstract][Full Text] [Related]
4. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective Effect of Whole Body Periodic Acceleration in Dystrophic Phenotype
Uryash A; Mijares A; Esteve E; Adams JA; Lopez JR
Front Physiol; 2021; 12():658042. PubMed ID: 34017265
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the cardiac sodium channel Nav1.5 by utrophin in dystrophin-deficient mice.
Albesa M; Ogrodnik J; Rougier JS; Abriel H
Cardiovasc Res; 2011 Feb; 89(2):320-8. PubMed ID: 20952415
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters.
Ramachandran J; Schneider JS; Crassous PA; Zheng R; Gonzalez JP; Xie LH; Beuve A; Fraidenraich D; Peluffo RD
Biochem J; 2013 Jan; 449(1):133-42. PubMed ID: 23009292
[TBL] [Abstract][Full Text] [Related]
8. Intracellular calcium handling in ventricular myocytes from mdx mice.
Williams IA; Allen DG
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H846-55. PubMed ID: 17012353
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy.
Delfín DA; Xu Y; Peterson JM; Guttridge DC; Rafael-Fortney JA; Janssen PM
J Transl Med; 2011 May; 9():68. PubMed ID: 21586145
[TBL] [Abstract][Full Text] [Related]
10. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
Chun JL; O'Brien R; Berry SE
Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
[TBL] [Abstract][Full Text] [Related]
11. Exacerbation of dystrophic cardiomyopathy by phospholamban deficiency mediated chronically increased cardiac Ca
Law ML; Prins KW; Olander ME; Metzger JM
Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1544-H1552. PubMed ID: 30118340
[TBL] [Abstract][Full Text] [Related]
12. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
13. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
[TBL] [Abstract][Full Text] [Related]
14. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
15. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.
Nakamura A; Harrod GV; Davies KE
Neuromuscul Disord; 2001 Apr; 11(3):251-9. PubMed ID: 11297940
[TBL] [Abstract][Full Text] [Related]
16. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.
Delfín DA; Zang KE; Schill KE; Patel NT; Janssen PM; Raman SV; Rafael-Fortney JA
Neuromuscul Disord; 2012 Nov; 22(11):1006-14. PubMed ID: 22749475
[TBL] [Abstract][Full Text] [Related]
19. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
Berry SE; Andruszkiewicz P; Chun JL; Hong J
Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
[TBL] [Abstract][Full Text] [Related]
20. Mechanical and non-mechanical functions of Dystrophin can prevent cardiac abnormalities in Drosophila.
Taghli-Lamallem O; Jagla K; Chamberlain JS; Bodmer R
Exp Gerontol; 2014 Jan; 49():26-34. PubMed ID: 24231130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]